GlassScriptPhysician profile
Scott S Prysi
NPI 1376546036
$2,563.57
in general payments reported to CMS, 2019-2025
18 companies · $23.51 in 2025
The $23.51 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $62.28 · 2021: $65.33 · 2022: $1,884 · 2023: $256 · 2024: $36.20 · 2025: $23.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $1,500.00 | 2022 | |
| Visby Medical, INC. | $237.64 | 2023 | Visby Medical Sexual Health Click Test |
| Mckesson Medical-Surgical, INC. | $177.08 | 2022 | |
| Jazz Pharmaceuticals INC. | $125.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $114.46 | 2022 | |
| Alkermes, INC. | $65.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $64.58 | 2019 | |
| Abbvie INC. | $54.51 | 2021-2024 | |
| Genentech USA, INC. | $39.64 | 2020-2021 | |
| Pfizer INC. | $35.47 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.11 | 2019 | |
| Hologic Sales and Service, LLC | $23.51 | 2025 | Thinprep 2000 Processor |
| Eisai INC. | $20.55 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.09 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $16.21 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $15.34 | 2021 | |
| Dermira, INC. | $13.25 | 2020 | |
| Allergan, INC. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Prysi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.